GlaxoSmithKline, U.K. Government Reach MenB Vaccination Agreement

The UK government has reached a deal with drug company GlaxoSmith Kline to be the first worldwide to routinely vaccinate babies against Meningitis B.  According to an article via PharmaTimes.com, “As a result Bexsero, the only licensed MenB vaccine, will now be...

Sanofi Agrees to R&D Partnership with Evotec

In an announcement via Genetic Engineering & Biotechnology News, “Evotec said yesterday it hammered out a definitive agreement for a five-year, minimum-guaranteed €250 million (nearly $270 million) strategic alliance with Sanofi focused on developing...